FDA warned Dr. Garber's Natural Solutions that website claims make Depression Relief an unapproved new drug and misbranded.
What happened
FDA reviewed www.drgarbers.com in January and February 2021 and found the site takes orders for Dr. Garber's Depression Relief. FDA found website claims, including relief of temporary depression or occasional sadness and a video titled "Dealing with post partum depression. naturally," that show the product is intended to treat disease.
What FDA found
The website claims show Dr. Garber's Depression Relief is intended to relieve depression and postpartum depression, so FDA treats it as a drug under federal law.
section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]The product is a new drug because FDA says it is not generally recognized as safe and effective for these uses and has no FDA approval.
section 201(p), sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 321(p), 331(d), 355(a)]The product is misbranded because it lacks adequate directions for a layperson to use it safely for a condition that needs a licensed practitioner's supervision.
section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]; 21 CFR § 201.5Offering this misbranded drug for interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. § 331(a)]
What FDA wants
FDA tells the company to take prompt action to address the violations and to notify FDA in writing within 15 working days of the steps taken, with documentation and a plan to prevent recurrence. If the company believes there is no violation, it must explain why with supporting information.
Who should pay attention
- marketers of supplements with disease-treatment claims
- retailers and online platforms selling Depression Relief
- companies making mental health-related products with drug-like claims
This is a summary. Read the original letter on fda.gov.